Novel formulation and clinical evaluation of nalidixic acid ointment in impetigo

被引：3
作者：
Tous, S. S. [1 ]
El Sayed, A. M. [1 ]
Abd El Mohsen, M. G. [1 ]
Youssef, E. M. K. [2 ]
Agban, M. N. [3 ]
Boushra, M. F. [1 ]
机构：
[1] Assiut Univ, Fac Pharm, Dept Pharmaceut, Assiut 71526, Egypt
[2] Assiut Univ, Fac Med, Dermatol Venerol & Androl Dept, Assiut 71526, Egypt
[3] Assiut Univ, Fac Med, Microbiol & Immunol Dept, Assiut 71526, Egypt
来源：
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 2012年 / 22卷 / 04期
关键词：
Nalidixic acid; Ointment; Release; Stability; Impetigo;
D O I：
10.1016/S1773-2247(12)50058-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The aim of this work was to formulate and evaluate nalidixic acid for the first time in different topical ointment bases. Among different ointment formulations, hydrocarbon base achieved the lowest release, while water-soluble base achieved the highest release. The presence of both isopropanol as cosolvent and nalidixic acid-sodium benzoate solid dispersion in formula (W8) enhanced both the release and the antibacterial activity of nalidixic acid compared to ointment formula (W5) containing neither of them. A stability study was also performed where no significant change in pH or drug content was observed in all stored formulations (W5 and W8). Stability was further checked by thin-layer chromatography (TLC). After clinical application in impetigo, it was found that the presence of isopropanol and nalidixic acid-sodium benzoate solid dispersion in ointment formulation (W8) caused a significant reduction in the mean time of healing (only four days) in impetigo patients.
引用
收藏
页码：347 / 352
页数：6
相关论文
共 31 条
  • [1] Abhijeet Pandey Abhijeet Pandey, 2010, Journal of Chemical and Pharmaceutical Research, V2, P182
  • [2] Aejaz A., 2010, Int J App Pharm, V2, P7
  • [3] Arunachalam A., 2010, Curr Pharm Res, V1, P82
  • [4] Aukunuru J, 2009, CURR TREND BIOTECHNO, V3, P97
  • [5] Balata G., 2010, ASIAN J PHARM SCI, V5, P1
  • [6] Methods of analysis olf 4-quinolone antibacterials
    Belal, F
    Al-Majed, AA
    Al-Obaid, AM
    [J]. TALANTA, 1999, 50 (04) : 765 - 786
  • [7] BIOPHARMACEUTICAL STUDIES ON SOLID DISPERSIONS OF NALIDIXIC-ACID IN MODIFIED STARCHES
    CHOWDARY, KPR
    RAO, PV
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (19) : 3015 - 3022
  • [8] Daniels Rolf, 2007, J Dtsch Dermatol Ges, V5, P367, DOI 10.1111/j.1610-0387.2007.06321.x
  • [9] ELFAHAM TH, 1992, PHARM IND, V54, P82
  • [10] ELFAHAM TH, 1989, PHARMAZIE, V44, P211
1234